FDNA Partners with Blueprint Genetics to Spotlight RASopathies During the Year of Discovery
FDNA’s Year of Discovery Initiative will spotlight a different genetic syndrome group each month as part of their mission to Read more
Phenotyping Adds a Face to Complement Genetics
Dr. Robert L. Stevenson of Labcompare discusses the use of phenotyping and facial analysis as an important supplement to molecular testing. Read more
Pinpointing Rare Diseases with Facial Analysis and Phenotyping Technology
Dekel Gelbman, CEO of FDNA, was featured in Medical Device and Diagnostics Industry, discussing the value of facial analysis technology Read more
Phenotyping technologies save on costs and improve rare disease workflows
Dekel Gelbman, CEO of FDNA, was featured in Becker’s Hospital Review, discussing the value of phenotyping to hospitals involved in Read more
FDNA Launches “Year of Discovery” for Rare Disease Day
FDNA Launches “Year of Discovery” for Rare Disease Day Boston-based health and tech start-up calls on patients and clinicians to share Read more